OR
emeis Société anonyme
ORPEF · OTC
$14.22 +0.00% (+$0.00)
Market Cap 1.98B €
P/E Ratio -
Div. Yield -
ROE 19.64%
Bulios Fair Price
$9.02
36.6% downside
Current Price
$14.22
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ORPEF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
86 /100
Cheap EV/EBITDA 12.09x
P/S 0.34x
P/B 1.41x
Growth
71 /100
Growing Rev. growth 7.98%
FCF growth 18.92%
EPS growth N/A
Profitability
19 /100
Weak Gross margin 3.58%
Net margin 5.06%
Op. margin 2.93%
Quality
8 /100
Poor ROIC 1.83%
ROE 19.64%
ROA 2.35%
Debt
4 /100
High Debt/Equity 5.98x
Current ratio 0.64x
Int. coverage 0.55x
Stability
56 /100
Moderate Beta 0.63x
Rev. volatility 3.26%
EPS volatility 111.23%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ORPEF
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Laurent Guillot
Employees
84,586
Headquarters
Puteaux
Upcoming events
23 SEP
Earnings
Upcoming earnings report